Detalhe da pesquisa
1.
High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes.
Haematologica
; 108(2): 532-542, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979720
2.
The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes.
Ann Hematol
; 101(5): 1023-1030, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35190844
3.
Patient-reported fatigue refines prognosis in higher-risk myelodysplastic syndromes (MDS): a MDS-CAN study.
Br J Haematol
; 194(2): 319-324, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060069
4.
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.
Transfusion
; 56(10): 2607-2614, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27465524
5.
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.
Transfusion
; 55(2): 253-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25125085
6.
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Leuk Lymphoma
; 64(3): 651-661, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606533
7.
Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes.
JCO Oncol Pract
; 19(4): e559-e569, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36763927
8.
Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation.
Transfusion
; 52(9): 2049-54, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22321053
9.
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.
Leuk Lymphoma
; 63(13): 3165-3174, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095125
10.
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.
Leuk Lymphoma
; 62(9): 2295-2297, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749497
11.
Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia.
Leuk Lymphoma
; 61(9): 2271-2273, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427017
12.
Revised 15-item MDS-specific frailty scale maintains prognostic potential.
Leukemia
; 34(12): 3434-3438, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855438